JAK1/JAK2i |
Baricitinib |
Approved |
Rheumatoid arthritis |
|
|
CTP-543 |
II, III |
Alopecia Areata |
NCT05041803; NCT03898479;
NCT04784533; NCT03941548; NCT03811912; NCT04797650;
NCT04518995 |
|
PF06700841 |
II |
Systemic Lupus Erythematosus |
NCT03845517; |
|
|
II |
Atopic Dermatitis |
NCT03903822 |
|
|
II |
Psoriatic Arthritis; Alopecia Areata |
NCT03963401 |
|
|
II |
Chronic Plaque; Psoriasis; Psoriasis |
NCT02969018;
NCT03850483 |
|
|
II |
Crohn’s Disease; Ulcerative Colitis |
NCT03395184;
NCT02958865 |
|
|
II |
Acne Inverse |
NCT04092452 |
|
|
II |
Alopecia Areata; Cicatricial Alopecia |
NCT02974868;
NCT05076006 |
|
|
II |
Active Non-segmental Vitiligo |
NCT03715829 |
|
Ruxolitinib
|
Approved
|
Polycythemia vera,
intermediate-high risk
myelofibrosis
|
|
|
Upadacitinib |
Approved |
Rheumatoid Arthritis |
|
JAK1/JAK3i |
ATI-501 |
II |
Alopecia; Areata Alopecia; Universalis
Alopecia; Totalis; |
NCT03759340; NCT03594227 |
|
ATI-502 |
II |
Alopecia Areata; Alopecia; Universalis Alopecia;
Totalis; Atopic Dermatitis |
NCT03759340; NCT03585296 |
|
Tofacitinib
|
approved
|
Rheumatoid Arthritis, Psoriatic
Arthritis, Ulcerative Colitis
|
|